menu
    • menu

    Company profile for Allecra Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Allecra Therapeutics, established in 2013, is a clinical-stage biopharmaceutical company contributing towards the global effort to combat antibiotic resistance by developing new therapeutic modalities to overcome emergent resistance mechanisms, thereby saving lives of patients whose infections may otherwise be treated inadequately. Allecra is supported by Forbion, Andera Partners, Delos Capital, Xeraya Capital, EMBL Venture...
    Allecra Therapeutics, established in 2013, is a clinical-stage biopharmaceutical company contributing towards the global effort to combat antibiotic resistance by developing new therapeutic modalities to overcome emergent resistance mechanisms, thereby saving lives of patients whose infections may otherwise be treated inadequately. Allecra is supported by Forbion, Andera Partners, Delos Capital, Xeraya Capital, EMBL Ventures, and BioMed Partners. Allecra’s wholly owned French subsidiary is a beneficiary of financial support from the French public bank Bpifrance and from the Région Alsace.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Allecra TherapeuticsGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Allecra Therapeutics GmbH Im Kränzliacker 9 79576 Weil am Rhein
    Telephone
    Telephone
    +33 3 8968 9876
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://allecra.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Global ChemShow

    Not Confirmed

    envelop Contact Supplier

    Global ChemShow

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Allecra & Acino Ink Agreement For Exblifep In GCC And South Africa
    Allecra & Acino Ink Agreement For Exblifep In GCC And South Africa

    25 Jun 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=169946&sid=2

    PHARMABIZ
    25 Jun 2024
    Share Share
    FDA says yes to Allecra's antibiotic combo after CRL for another
    FDA says yes to Allecra's antibiotic combo after CRL for another

    27 Feb 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/one-one-down-allecra-scores-fda-nod-antibiotic-combo-after-venatorx-hit-crl

    FIERCE PHARMA
    27 Feb 2024
    Share Share
    Xentria & Meitheal Announce Exclusive Licensing Agreement for XTMAB-16
    Xentria & Meitheal Announce Exclusive Licensing Agreement for XTMAB-16

    27 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230627396707/en

    BUSINESSWIRE
    27 Jun 2023
    Share Share
    Allecra Submits NDA to the U.S. FDA for EXBLIFEP® for Complicated UTI
    Allecra Submits NDA to the U.S. FDA for EXBLIFEP® for Complicated UTI

    27 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230627361506/en

    BUSINESSWIRE
    27 Jun 2023
    Share Share
    Allecra Therapeutics Publishes Final Phase 3 ALLIUM Data in JAMA
    Allecra Therapeutics Publishes Final Phase 3 ALLIUM Data in JAMA

    05 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221005005413/en

    BUSINESSWIRE
    05 Oct 2022
    Share Share
    Allecra, ADVANZ PHARMA Sign Exclusive Agreement for Cefepime/enmetazobactam
    Allecra, ADVANZ PHARMA Sign Exclusive Agreement for Cefepime/enmetazobactam

    12 Jan 2022

    // BIOSPACE

    https://www.biospace.com/article/releases/allecra-therapeutics-and-advanz-pharma-sign-exclusive-license-and-supply-agreement-for-allecra-s-antibiotic-cefepime-enmetazobactam-in-europe/

    BIOSPACE
    12 Jan 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search